Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palonosetron for prevention of chemotherapy-induced nausea and vomiting in non-Hodgkin lymphoma
2008-007827-14Phase 4Terminated
- Sponsor
- Helsinn
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of palonosetron in chemotherapy-induced nausea and vomiting (CINV), sponsored by Helsinn. Primary endpoints: Complete response during overall phase, Complete response during acute phase and 1 more. Started Aug 2009; status: terminated.
02
Drugs
palonosetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on 2008-007827-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007827-14.